You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

denosumab

Showing 1 - 25 of 126
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteoporosis in Postmenopausal Women Trial (Eldecalcitol, Native Vitamin D, Denosumab)

Not yet recruiting
  • Osteoporosis in Postmenopausal Women
  • (no location specified)
Jun 1, 2023

Denosumab Allergy Trial in Shenzhen (Denosumab, Alendronate, Placebo)

Recruiting
  • Denosumab Allergy
  • Denosumab
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen People's Hospital
Dec 21, 2022

Osteoporosis, Spine Fusion, Denosumab Allergy Trial in Shenzhen (Denosumab, Placebo)

Completed
  • Osteopenia
  • +2 more
  • Denosumab
  • Placebo
  • Shenzhen, Guangdong, China
    ShenzhenPH
Jan 15, 2023

Chronic Kidney Diseases, Fracture, Bone Density, Low Trial in Beijing (Denosumab, Non-denosumab)

Recruiting
  • Chronic Kidney Diseases
  • +3 more
  • Beijing, Beijing, China
    Nephrology Department of Beijing Jishuitan Hospital
Jan 20, 2023

Denosumab Safety Assessment in Multiple Observational Databases

Active, not recruiting
  • Osteoporosis
  • (no location specified)
Jan 13, 2023

Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Denosumab
  • Rochester, New York
    University of Rochester
Oct 3, 2022

Adult Idiopathic Generalized Osteoporosis Trial in Omaha, New York (Denosumab)

Completed
Has Results
  • Adult Idiopathic Generalized Osteoporosis
  • Denosumab
  • Omaha, Nebraska
  • +1 more
Nov 15, 2022

Primary Hyperparathyroidism Trial in New York (Denosumab, Placebo)

Terminated
Has Results
  • Primary Hyperparathyroidism
  • Denosumab
  • Placebo
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Bone Metastases Trial (Denosumab, Zoledronic Acid)

Completed
Has Results
  • Bone Metastases
  • Denosumab
  • Zoledronic Acid
  • (no location specified)
Nov 4, 2022

Osteoporosis, Postmenopausal Trial in Jaipur (Denosumab, Denosumab-Ref)

Recruiting
  • Osteoporosis, Postmenopausal
  • Jaipur, Rajasthan, India
    S. R. Kalla Memorial Gastro & General Hospital
Aug 16, 2022

Fibrous Dysplasia Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (denosumab)

Recruiting
  • Fibrous Dysplasia
  • denosumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 15, 2022

Osseointegrated Implants, Bone Mineral Density Trial (Denosumab, Placebo)

Completed
  • Osseointegrated Implants
  • Bone Mineral Density
  • Denosumab
  • Placebo
  • (no location specified)
Feb 20, 2023

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Denosumab
  • +2 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures Trial in Pittsburgh (denosumab, Placebo, Calcium and Vitamin

Active, not recruiting
  • Osteoporosis, Postmenopausal
  • +2 more
  • denosumab
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Senior Communities
Sep 7, 2022

Sarcopenia, Osteoporosis Trial in Pittsburgh (Denosumab, Zoledronic Acid, Denosumab Placebo)

Not yet recruiting
  • Sarcopenia
  • Osteoporosis
  • Denosumab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 2, 2023

Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

Active, not recruiting
  • Bone Diseases
  • Pain
  • Denosumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 17, 2022

Osteoporotic Fractures Trial (Denosumab, Teriparatide)

Not yet recruiting
  • Osteoporotic Fractures
  • (no location specified)
May 9, 2023

Healthy Trial in Newark, Rennes (Denosumab)

Completed
  • Healthy
  • Denosumab
  • Newark, New Jersey
  • +1 more
Nov 24, 2022

Breast Cancer Trial in Stony Brook (Denosumab)

Completed
  • Breast Cancer
  • Denosumab
  • Stony Brook, New York
    Stony Brook University Cancer Center
Jan 19, 2022

Bariatric Surgery Candidate, Bone Loss Trial in San Francisco, Boston (Denosumab, Placebo, Zoledronic Acid)

Recruiting
  • Bariatric Surgery Candidate
  • Bone Loss
  • Denosumab
  • +2 more
  • San Francisco, California
  • +1 more
Apr 4, 2022

Revision Surgery of Total Hip Arthroplasty Trial in Sheffield (Denosumab, Placebo)

Completed
  • Revision Surgery of Total Hip Arthroplasty
  • Denosumab
  • Placebo
  • Sheffield, South Yorkshire, United Kingdom
    Academic Unit of Bone Metabolism
Feb 1, 2022

Melanoma Stage Iv, Melanoma Stage Iii, Melanoma Trial in Australia (Denosumab, Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma Stage Iv
  • +2 more
  • Denosumab
  • +2 more
  • Albury, New South Wales, Australia
  • +9 more
Apr 6, 2022

Patients of Unresectable Giant Cell Tumor of Bone

Completed
  • Giant Cell Tumor of Bone
  • Denosumab
  • Beijing, Beijing, China
  • +2 more
May 30, 2022

Low Bone Mineral Density, Postmenopausal Osteoporosis Trial (Placebo to Romosozumab, Alendronate, Teriparatide)

Completed
Has Results
  • Low Bone Mineral Density
  • Postmenopausal Osteoporosis
  • Placebo to Romosozumab
  • +6 more
  • (no location specified)
Sep 9, 2022

Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)

Completed
  • Urothelial Carcinoma
  • +3 more
  • Denosumab
  • +6 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 22, 2021